The Presence of ANCA in IgA Crescentic Nephropathy Does Not Lead to Worse Prognosis with Intensive Rescue Treatment
暂无分享,去创建一个
M. Soler | O. Bestard | I. Agraz | N. Ramos | Sheila Bermejo | Mónica Bolufer | R. Bury | Zaira Castañeda | Alejandra Gabaldón | María Teresa Sanz-Martínez | Marina López-Martínez | L. Viñas Gimenez | A. Gabaldón | M. Sanz-Martínez
[1] Hong Zhang,et al. O-glycoforms of polymeric IgA1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes. , 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] Gabriel Ștefan,et al. IgA nephropathy with serum ANCA positivity: case series and literature review , 2021, Rheumatology International.
[3] Jianghua Chen,et al. The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides With Glomerular IgA Deposition , 2019, Applied immunohistochemistry & molecular morphology : AIMM.
[4] Su-xia Wang,et al. A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.
[5] Min Chen,et al. Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case–control study , 2015, Clinical kidney journal.
[6] Birgitte Bang Pedersen,et al. Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum? , 2015, Clinical kidney journal.
[7] K. Ivens,et al. Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] Fernand,et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. , 2009, Kidney international.
[9] J. Bonet,et al. [IgA nephropathy with crescentic glomerulonephritis and ANCA positive]. , 2005, Nefrología.
[10] T. Dougan,et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. , 2004, Kidney international.
[11] S. Adler,et al. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] S. Rosen,et al. IgG antineutrophil cytoplasmic antibodies in IgA nephropathy: a clinical variant? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] R. Coppo,et al. Properties of circulating IgA molecules in Henoch-Schönlein purpura nephritis with focus on neutrophil cytoplasmic antigen IgA binding (IgA-ANCA): new insight into a debated issue. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura in adults and in children. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] E. Ritz,et al. Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. , 1997, Clinical nephrology.
[15] Masaki Kobayashi,et al. Natural history and risk factors for immunoglobulin a nephropathy in Japan , 1997 .
[16] G. D'Amico,et al. Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy. , 1994, Clinical immunology and immunopathology.
[17] D. O'donoghue,et al. Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura. , 1991, The Journal of clinical investigation.
[18] G. D'Amico,et al. The commonest glomerulonephritis in the world: IgA nephropathy. , 1987, The Quarterly journal of medicine.